Gedeon Richter PLC (GDRB)

8,650.0
+40.0(+0.46%)
  • Volume:
    0
  • Bid/Ask:
    8,645.0/8,665.0
  • Day's Range:
    8,615.0 - 8,665.0
  • Type:Equity
  • Market:Hungary
  • ISIN:HU0000123096

GDRB Overview

Prev. Close
8,610
Day's Range
8,615-8,665
Revenue
584.89B
Open
8,615
52 wk Range
6,280-9,320
EPS
552.04
Volume
0
Market Cap
1.6T
Dividend (Yield)
225.00
(2.56%)
Average Vol. (3m)
215,239
P/E Ratio
15.12
Beta
0.57
1-Year Change
28.89%
Shares Outstanding
185,635,207
Next Earnings Date
Nov 08, 2021
What is your sentiment on Gedeon Richter PLC?
or
Vote to see community's results!

Gedeon Richter PLC Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyNeutralSellBuyStrong Buy
Technical IndicatorsStrong BuyStrong BuyStrong SellBuyStrong Buy
SummaryStrong BuyBuyStrong SellBuyStrong Buy

Gedeon Richter PLC Company Profile

Gedeon Richter PLC Company Profile

Employees
12842
Market
Hungary

Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. researches, develops, manufactures, markets, and sells pharmaceutical products worldwide. The company operates through two segments, Pharmaceuticals, and Wholesale and Retail. It develops and manufactures products in various therapeutic areas, including women’s healthcare, cardiovascular, and central nervous system. The company women’s healthcare products include contraceptives, endometriosis, fertility, menopause, vaginal infections, and preparations used for the treatment of uterine fibroids. It also offers central nervous system products, such as products for the treatment of chronic cerebral circulatory disorders and neuropathic pain; and anaesthetics, anti-anxiety medications, sleeping pills, and anti-epileptic medicines, as well as products for the prevention and treatment of various cardiovascular diseases. In addition, the company produces various over-the-counter products for various health problems comprising Escapelle and Postinor, an emergency contraceptive pill; Panangin and Folik for pregnancy supplementation; Stopdiar and Nifuroxazide to treat diarrhea; RICHTER CycleBalance for infertility and PCOS; Groprinosin for antiviral and immunostimulant; Moilec for back and joint pain; Fasconal, a pain relief tablet; Magnezin, a magnesium supplementation; Aflamil, an anti-inflammatory and antirheumatic cream; Oralsept, a sore throat, anti-inflammatory, local anesthetic, and before and after oral surgery spray; Lordestin for allergy; and Curiosin for wound care. Further, it provides financial and accounting, social welfare, portfolio and project management, catering, carriage transportation, engineering, quality control, trading, asset management, and biotechnological services. The company was founded in 1901 and is headquartered in Budapest, Hungary.

Read More
  • 2021.06.03. Az osztalékra jogosító részvények megszerzésének utolsó napja! Hajrá!
    0
    • Vettem :)
      0
  • 8050?
    2
    • 🚀🚀🚀
      0
      • Chart by Thomas.
        0
        • 6000, then 5800
          5
          • Let’s get 6600
            0
            • Company has distributed 2 billion shares (320 534) among employees.
              1
              • Next stop at 6,500 LOL
                0
                • downtrend on 4 hours chart. Have to reach a Strong support level. Bullish candles need on 1 day chart, and bullish price action have to see on 4 hours chart.
                  0
                  • Long
                    0
                • "The letter from the FDA indicates it is not able to approve the ulipristal acetate NDA in its current form and is requesting additional information." HODL
                  0
                  • FDA's decision about Richter's Esmya product introduction to the USA market takes place today. Strong fundamental impact. I went long. Let's go baby!
                    0
                    • Buy the dip folks.
                      0
                      • Fasten your seatbelts! We're taking off.
                        0
                    • Why is so weak, it could be above 6.500
                      0
                      • go to short
                        0
                        Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                        Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.